• COVID-19
  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

4 Predictions for Diabetes Management and Technology in 2021

by Jordan Messler, MD, SFHM, FACP, Executive Director, Clinical Practice, Glytec 01/08/2021 Leave a Comment

Is Glucometrics The Missing Data in the Fight Against COVID-19?

Jordan Messler, MD, SFHM, FACP, Executive Director, Clinical Practice, Glytec The COVID-19 pandemic continues to put an unprecedented amount of strain on the entire healthcare sector, and the industry has responded by accelerating the ways innovation is developed and adopted. Health leaders have faced a generational challenge and the result has been the rapid deployment of technology to address dire patient needs. Health systems, physicians, and frontline staff pulled together in remarkable
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Digital Diabetes Market to Reach $1.5B by 2024, Research Finds

by Jasmine Pennic 12/14/2020 Leave a Comment

Diabetes Management Apps Global Mobile Health Solutions_7 Best Practices for Developing Successful Diabetes Mobile Apps

What You Should Know: - The digital diabetes market is on track to reach $1.5 billion dollars by 2024, according to a new report by Research2Guidance. - The confident growth of digital diabetes care will be driven by the growth of the global addressable market for digital diabetes services. Between 2019 and 2024, the number of diagnosed diabetics with access to smart devices is set to increase from 109 million to 180 million.  - Digital diabetes solutions have disrupted the
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Ascensia Diabetes Care Partners With VisiQuate to Expand Beyond Blood Glucose Monitoring

by Jasmine Pennic 09/23/2020 Leave a Comment

Ascensia Diabetes Care Partners With VisiQuate to Expand Beyond Blood Glucose Monitoring

What You Should Know: - Ascensia Diabetes Care and VisiQuate announced a partnership to expand beyond blood glucose monitoring and provide holistic diabetes management solutions. - The overall solution will provide integration with Ascensia’s existing devices and digital diabetes solutions to enable it to capture data from patients who have consented to provide their information. Ascensia Diabetes Care, a Santa Rosa, CA-based provider of blood glucose monitoring systems
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

State of Connecticut Launches of Livongo for Diabetes Management Program through State Health Plan

by Jasmine Pennic 05/08/2020 Leave a Comment

State of Connecticut Launches of Livongo for Diabetes Management Program through State Health Plan

What You Should Know: - Connecticut state Comptroller Kevin Lembo announces the launch of Livongo for Diabetes Management Program through the state health plan to deliver estimated annual savings to the state of approximately $3 million. - The program, launched in partnership with CVS Caremark and Livongo, is projected to significantly improve health care outcomes for thousands of people with diabetes covered by the state plan by providing them with comprehensive around-the-clock live
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

COVID-19: Glooko Offers Free Remote Care to Medical Clinics and People with Diabetes

by Fred Pennic 03/19/2020 Leave a Comment

COVID-19 Pandemic: Glooko Offers Free Remote Care to Medical Clinics & Patients with Diabetes

What You Should Know: - Glooko today announced that during the COVID-19 pandemic they are taking action to serve the global diabetes community by providing a no-charge remote care solution that provides live patient-to-clinician connectivity. - To minimize the risk to people with diabetes during this time by broadening access to a remote medical appointment with healthcare providers, Glooko is offering its secure, privacy-protected remote care solution at no charge to medical clinics and
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

BCBS Kansas City to Offer Livongo for Diabetes Program to All Fully Insured Clients

by Fred Pennic 10/17/2019 Leave a Comment

UCSF Launches SUGAR Clinical Trial Study to Compare Livongo’s Diabetes Management Program to Standard Diabetes Care

- Livongo announced an expanded partnership with Blue Cross and Blue Shield of Kansas City to provide Livongo for Diabetes program to all Blue KC fully insured clients. - Blue KC was an early Livongo adopter and this expansion provides momentum as we continue to expand from working primarily with self-insured employers to broader markets including fully insured populations of our health plan clients.Livongo Health, Inc. (Nasdaq: LVGO), an Applied Health Signals company empowering people with
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Drugmaker Bayer to License One Drop’s Digital Diabetes Management Platform, Leads $40M Series B Funding

by Fred Pennic 09/17/2019 Leave a Comment

Apple to Sell One Drop’s Blood Glucose Monitors in Select Retail Stores

- Drugmaker Bayer leads One Drop’s $40M Series B funding round and enters commercial agreement to license One Drop's digital diabetes management platform in its global bio-digital efforts in therapeutic areas. - Bayer will leverage One Drop's data science and predictive capabilities, and harness its mobile platform to deliver innovative bio-digital solutions across a broad array of therapeutic areas.- One Drop provides personalized health programs to drive sustainable behavior change as part of
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Apple to Sell One Drop’s Blood Glucose Monitors in Select Retail Stores

by Fred Pennic 06/27/2019 Leave a Comment

Apple to Sell One Drop’s Blood Glucose Monitors in Select Retail Stores

One Drop, a digital blood glucose monitoring kit for diabetes management will now be available in select retail Apple stores, CNBC reports. Currently sold online in the Apple Store for $69.95, the digital diabetes kit includes a Bluetooth glucose meter, test strips, lancets (optional), and one year of free coaching from a certified diabetes coach.One Drop Blood Glucose MonitorOne Drop’s blood glucose meter ensures clinically proven accurate, reliable results in just five seconds. The meter then
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Companion Medical Integrates Smart Insulin Pen with Rimidi Diabetes Management App

by Jasmine Pennic 06/07/2019 Leave a Comment

Glooko Integrates Insulin Data with Companion Medical’s Smart Insulin Injection Pen

Rimidi and Companion Medical announced a first-of-its-kind partnership to enhance data visualization for clinicians treating high-risk patients with diabetes who are on insulin therapy. The collaboration integrates Companion Medical’s connected device, InPen™, the first and only FDA-cleared, smart insulin pen paired with an integrated diabetes management app, into Rimidi’s platform by pushing insulin dosing data from the InPen through the cloud.Integration BenefitsThis partnership reduces the
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Glooko Integrates Insulin Data with Companion Medical’s Smart Insulin Injection Pen

by Jasmine Pennic 06/05/2019 Leave a Comment

Glooko Integrates Insulin Data with Companion Medical’s Smart Insulin Injection Pen

Glooko and Companion Medical have announced an integrated data partnership agreement that will enable insulin data from users of the InPen Smart Insulin Injection Pen to be integrated into the Glooko Enterprise diabetes data management system and Glooko Mobile App. Impact of Integration The announcement of this integration is significant because InPen is the first “smart” insulin pen to introduce its data integration and compatibility with the Glooko platform
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]
  • 1
  • 2
  • 3
  • 4
  • Next Page

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Read

  • CVS Health Launches Senior Medical Alert System, Symphony CVS Health Launches Senior Medical Alert System, Symphony
  • 30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021 30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021
  • 20 COVID-19 Predictions and Trends for 2021 - Executive Roundup 20 COVID-19 Predictions and Trends for 2021 – Executive Roundup
  • 20 COVID-19 Predictions and Trends for 2021 - Executive Roundup MEDITECH Launches Quick Vaccination Solution to Streamline COVID-19 Vaccination Process
  • ONC Issues First Health IT Standards Bulletin Discussing USCDI & SVAP ONC Issues First Health IT Standards Bulletin Discussing USCDI & SVAP
  • 16 COVID-19 Predictions and Trends for 2021 Executive Roundup 12-Available-COVID-19-Vaccine-Management-Solutions-to-Know-In-Depth-1 17 Recently Launched COVID-19 Vaccine Management Solutions to Know
  • FDA Approves COVID-19 Oral Fluid Test for Use Nationwide In-Depth: 32 FDA-Approved COVID-19 Testing Kits
  • COVID-19 Deferrals Lead to 3 Major Conditions Payers/Providers Must Address in 2021 COVID-19 Deferrals Lead to 3 Major Conditions Payers/Providers Must Address in 2021
  • Heritage Group Healthcare PE Firm Heritage Group Launches $300M Health Tech Fund
  • 5G in Healthcare: 7 Advantages & Disadvantages for Providers to Know 5G in Healthcare: 7 Advantages & Disadvantages for Providers to Know

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2020 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2021. HIT Consultant Media. All Rights Reserved. Privacy Policy |